Chiesi Slovenija

Chiesi Slovenija is the Slovenian subsidiary of the Chiesi Group, an international research-focused biopharmaceutical group headquartered in Parma, Italy. The company specializes in the development and commercialization of innovative therapeutic solutions across three primary areas: Air (respiratory health), Rare (rare and ultra-rare diseases), and Care (special care and neonatology). Key products in its portfolio include the fixed-dose triple therapy Trimbow for COPD and asthma, the surfactant Curosurf for neonatal respiratory distress, and the stem cell therapy Holoclar. As a certified B Corp, Chiesi Slovenija integrates social and environmental sustainability into its business operations while providing medical support and pharmaceutical distribution within the Adriatic region.